Alyeska Investment Group
ZSAN

Alyeska Investment Group’s Zosano Pharma Corporation ZSAN Stock Holding History

Alyeska Investment Group’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-8,456
Closed -$479K – 651
2020
Q3 		$479K Hold
8,456
– – 0.01% 418
2020
Q2 		$253K Sell
8,456
-1,189
-12% -$33.6K ﹤0.01% 456
2020
Q1 		$190K Sell
9,645
-208
-2% -$6.97K ﹤0.01% 353
2019
Q4 		$524K Sell
9,853
-2,302
-19% -$142K 0.01% 356
2019
Q3 		$664K Sell
12,155
-6,738
-36% -$604K 0.01% 345
2019
Q2 		$2.16M Buy
+18,893
New +$2.24M 0.03% 313

Other funds holding ZSAN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Alyeska Investment Group's ZSAN Position: Q4 2020 in Review

Alyeska Investment Group sold out of Zosano Pharma Corporation (ZSAN) in Q4 2020, closing a stake of 8,456 shares — an estimated $479K sold.

Alyeska Investment Group first reported a position in ZSAN in Q2 2019 and held it in 6 quarters. The position peaked at $2.16M in Q2 2019. 34 funds tracked by Wall St. Rank hold ZSAN as of Q4 2020.

  • Alyeska Investment Group reported no remaining Zosano Pharma Corporation position as of Q4 2020 after selling out during the quarter.
  • Alyeska Investment Group sold 8,456 Zosano Pharma Corporation shares in Q4 2020, an estimated $479K.
  • Alyeska Investment Group first reported a position in Zosano Pharma Corporation in Q2 2019 and held it in 6 quarters.
  • Alyeska Investment Group's Zosano Pharma Corporation position peaked at $2.16M in Q2 2019.
  • 34 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q4 2020.

Based on Alyeska Investment Group's 13F filing for Q4 2020, filed 16 Feb 2021.